Skip to content

To explore the effect mechanism of Baduanjin training on post-stroke cognitive impairment

To explore the effect mechanism of Baduanjin training on post-stroke cognitive impairment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076533
Enrollment
Unknown
Registered
2023-10-11
Start date
2023-11-01
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Poststroke cognitive impairment

Interventions

Left hemisphere stroke stroke training:Five times per week for 40 minutes for 12 weeks
Right hemisphere stroke stroke training:Five times per week for 40 minutes for 12 weeks
Conventional treatment group:The specific treatment plan is formulated by the doctor of the patient s diagnosis and treatment hospital. The staff of this research group do not participate in the treat

Sponsors

The People's Hospital of Bao'an, Shenzhen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: ? Meet the diagnostic criteria for stroke, (Refer to the Diagnosis Points of Major Cerevascular Diseases in China 2019 revised by the Expert Committee of Neurology Branch of Chinese Medical Association); ? with mild cognitive impairment, (As per the American Diagnostic and Statistical Manual of Mental Disorders, Version V (Diagnostic and Statistical Manual Disoeders, 5th edition, Diagnostic criteria for "mild vascular neurocognitive impairment" in DSM-V); ? first stroke, =1 year; ? 45 =age= 75 years; ? stable, Consciousness, Stable vital signs; ? can safely walk 10 m or more without physical and auxiliary equipment assistance; ? right hand; ? informed consent, voluntary participation.

Exclusion criteria

Exclusion criteria: ? With brain tumor, brain trauma, brain parasitic disease and other diseases that can cause cognitive dysfunction; ? with severe speech, visual impairment, hearing impairment, or mental disorder; ? with previous medical records or clinician or family members have previous cognitive impairment or used drugs for cognitive impairment before the onset; ? Beck Depression Scale Version 2 (BDI-)> 13; ? with history of alcohol and drug abuse; ? with severe heart, liver, kidney, endocrine system and hematopoietic system; ? Other clinical trials who are participating in the trials influencing the evaluation of the results of this study.

Design outcomes

Primary

MeasureTime frame
Assessment of cognitive function;Assessment of cognitive function;

Secondary

MeasureTime frame
Evaluation of all dimensions of cognition;Assessment of motor function;Participation level assessment;Activities of daily living;

Countries

China

Contacts

Public ContactYiwen Wan

Shenzhen Baoan District People's Hospital

402510767@qq.com+86 191 4648 0050

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026